The role of aflibercept in the management of diabetic macular edema

Diabetic macular edema (DME) represents one of the leading causes of visual impairment in working-age adults. Although there are several proven treatments available for this condition, pharmacotherapy through the use of intravitreal antivascular endothelial growth factor agents has revolutionized th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Andrew A, Hong, Thomas, Ewe, Shaun Y, Bahrami, Bobak, Broadhead, Geoffrey K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532215/
https://www.ncbi.nlm.nih.gov/pubmed/26273198
http://dx.doi.org/10.2147/DDDT.S62778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532215/
https://www.ncbi.nlm.nih.gov/pubmed/26273198
http://dx.doi.org/10.2147/DDDT.S62778

Ejemplares similares